Project Number 5I01RX001305-05 Agency/Funding Organization United States Department of Veterans Affairs (VA) Funding Year 2019 View Full Project Details for Novel EPO peptide therapy for a new mouse model of dementia Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 9. Immunity and Inflammation d. Immunotherapy - Mechanisms of Action Researcher and Organization Principal Investigator DOWLING, PETER C Principal Investigator First Name DOWLING Principal Investigator Last Name PETER C Awardee Organization VA NEW JERSEY HEALTH CARE SYSTEM Awardee State New Jersey Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-RX-14-002: RR&D MERIT REVIEW AWARD FOR RESEARCH ON AMYOTROPHIC LATERAL SCLEROSIS, PARKINSON^S DISEASE AND ALZHEIMER^S DISEASE FY Overall Cost $0 Funding Organization Agency/Funding Organization United States Department of Veterans Affairs (VA) Funding Organization Country United States Program Official Unavailable
